Winners keep winning. That certainly seems to be the case over at Eli Lilly (NYSE: LLY). In the past year, the drugmaker has been one of the best performers in its industry -- and it's still going strong.

The company's shares recently jumped following its second-quarter earnings result. All in all, Eli Lilly's stock is up nearly 75% in the trailing-12-month period, bringing its market capitalization to about $500 billion. That's well into mega-cap territory.

Thankfully, Eli Lilly's recent run does not mean it is too late to buy its shares. Here are three reasons why investors can still confidently do so. 

Continue reading

Source Fool.com